Lynderm Research Inc. /ID# 201050

Markham, Ontario L3P 1X2

0 studies enrolling now · 1 studies all time

What they study most

Dermatitis

Studies at this site

• A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis — Completed